( click to enlarge )
Arca Biopharma Inc (NASDAQ:ABIO) broke out of a bottom/accumulation pattern today, as the stock closed up 47c or 8.94% on heavy volume, closing above the 50-day EMA for the first time in months. Today’s high is resistance for a follow through move on Tuesday. Looking at the technical chart above MACD and ADX both signal positive strength. The stock still trading above 9-day and 20-day exp moving average, also a bullish sign. Plus, the company will make a presentation at the 27th Annual Piper Jaffray Healthcare Conference on Tuesday, December 1 2015. I believe this conference on Wednesday could be a positive catalyst for ARCA biopharma shares.
( click to enlarge )
Acacia Research Corp (NASDAQ:ACTG) has been floating around 5.17-5.5 for several trading sessions and I still think the stock could see a sharp move higher from here. Daily technical chart indicates the stock is tremendously oversold, but the RSI is improving and the slow Stochastic is turning higher in oversold zone. If it breaks higher above 5.62 or 9EMA, it could go as high as 6.38 in short-term.
( click to enlarge )
JD Com Inc (NASDAQ:JD) finally broke out of the consolidation range that I've discussed lately. The stock hit a high of 31.07 and a low of 29.99 during the day. A break over today's high could push it to test $32. The near-term outlook is bullish for the stock. MACD is positive and above the signal line. RSI is moving up and above its 50% level. Long setup.
( click to enlarge )
PACCAR Inc (NASDAQ:PCAR) I like the idea of getting long with a stop below $50. The MACD is making a bullish crossover and the RSI is also rising. On watch.
( click to enlarge )
AEterna Zentaris Inc. (NASDAQ:AEZS) has finally closed above its 50-day exponential moving average currently placed around levels of $7.28 and it did so on heavy volume. Plus, the MACD indicator has just started to increase and the RSI is also showing positive signs on the stock. Stock price is expected to at least rally the next resistance at $9.70 and even go higher to test the 200-day EMA at $13.37
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
Labels: ABIO, ACTG, AEZS, JD, PCAR